$25-$30k a few times over is not enough money to finance their drug to market operation. Makes perfect sense the company would be unaware of any market manipulation (if that's the case) because that's not the $$$ they need to get Brem on the shelf.
MMs and professional investors might be employing their own strategies, but that's their right after buying shares of a public security.
This is all part of the PTN story, which is still ongoing.
News 
Market Data 
Discover 
